Syndax Pharmaceuticals
SNDX
#6582
Rank
NZ$1.43 B
Marketcap
NZ$15.94
Share price
-4.49%
Change (1 day)
-48.68%
Change (1 year)

Earnings for Syndax Pharmaceuticals (SNDX)

Earnings in 2026 (TTM): -NZ$0.37 Billion

According to Syndax Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2025 the company made an earning of -NZ$0.53 Billion, an increase over its 2024 earnings that were of -NZ$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Syndax Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.37 Billion-29.8%
2025 -NZ$0.53 Billion-10.46%
2024 -NZ$0.59 Billion52.25%
2023 -NZ$0.39 Billion40.19%
2022 -NZ$0.28 Billion-699.13%
2021 NZ$45.56 M-134.07%
2020 -NZ$0.14 Billion30.53%
2019 -NZ$0.11 Billion-24.22%
2018 -NZ$0.14 Billion21.64%
2017 -NZ$0.12 Billion36.72%
2016 -NZ$81.3 Million84.39%
2015 -NZ$44.09 Million21.64%
2014 -NZ$36.25 Million39.92%
2013 -NZ$25.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA